Benign prostatic hyperplasia in primary care: what you need to know

Area of Science:

• Urology
• Andrology

Background:

• Benign prostatic hyperplasia (BPH) is a common histological diagnosis.
• BPH can lead to benign prostatic obstruction (BPO) and other medical issues.
• Enlarged prostate and BPO require treatment only when symptoms are bothersome, progression is likely, or cancer is suspected.

Purpose of the Study:

• Review current literature and guidelines on BPO prevalence, pathophysiology, and management.
• Discuss management of lower urinary tract symptoms (LUTS) secondary to BPH.

Main Methods:

• Comprehensive review of published literature.
• Analysis of current treatment concepts and guidelines for BPO diagnosis and treatment.

Main Results:

• BPO is a treatable condition with available medical and surgical options.
• Effective treatments can significantly improve patient quality of life.
• Treatment decisions should consider symptom severity, risk of progression, and suspicion of cancer.

Conclusions:

• Benign prostatic obstruction (BPO) is highly treatable through collaborative patient management.
• Pharmacological agents and minimally invasive procedures are generally preferred over invasive surgery.
• Mild to moderate BPH symptoms can be managed by primary care physicians; complex cases require urologist referral.